Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial.

ABSTRACT:

SUBMITTER: Schilling WHK 

PROVIDER: S-EPMC7615401 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature